Second Primary Cancer and Early-onset Colorectal Cancer
May 16, 2024 updated by: LI XIN-XIANG
Risk Factors, Cancer Types and Prognostic Significance of Second Primary Cancer Based on the Early-onset and Late-onset Colorectal Cancer
The objective of this study was to analyze the pathological factors influencing the occurrence and prognosis of SPC in CRC patients of varying ages and compare the differences in the patterns of SPC occurrence and prognosis among patients of different age groups.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
10000
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Patients retrieved from the database of Fudan University Shanghai Cancer Center.
These patients were diagnosed with CRC primary tumors between January 2008 and December 2018.
Description
Inclusion Criteria:
- Patients undergoing radical surgery for colorectal cancer at Fudan University Shanghai Cancer Center between January 2008 and December 2018.
- Stage Ⅰ-Ⅳ colorectal cancer confirmed by clear pathological information
Exclusion Criteria:
- Previous history of other cancers before surgery
- Patients under 18 years old or over 80 years old
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
<50 years
|
no intervention
|
|
50-69 years
|
no intervention
|
|
≥70 years
|
no intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
overall survival
Time Frame: The duration from the date of surgery to death for any reason or the last recorded follow-up, whichever comes first. Up to 100 months
|
The duration from the date of surgery to death for any reason or the last recorded follow-up, whichever comes first. Up to 100 months |
The duration from the date of surgery to death for any reason or the last recorded follow-up, whichever comes first. Up to 100 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 11, 2024
Primary Completion (Estimated)
May 20, 2024
Study Completion (Estimated)
June 1, 2024
Study Registration Dates
First Submitted
May 11, 2024
First Submitted That Met QC Criteria
May 16, 2024
First Posted (Actual)
May 21, 2024
Study Record Updates
Last Update Posted (Actual)
May 21, 2024
Last Update Submitted That Met QC Criteria
May 16, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CRCSPM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.